Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection
- PMID: 2187809
- PMCID: PMC258727
- DOI: 10.1128/iai.58.6.1807-1811.1990
Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection
Abstract
Observations made during the study of nonspecific enhancement of antimicrobial host defenses permitted some physiologic dissection of the anatomic basis for normal protective processes. Local growth of bacteria in the hind limb in muramyl dipeptide-treated mice was suppressed modestly, but lymphatic filtration was markedly improved, especially between the ipsilateral groin and iliac lymph nodes. Spontaneous containment, when it occurred in saline-treated controls, proceeded similarly. Certain regional lymph nodes acted to restrict the dissemination of bacteria from an anatomically isolated infection, reducing the degree of bacteremia and improving survival. Containment of local bacterial infection appears more important in a favorable host response than does dispersion and is accentuated by muramyl dipeptide.
Similar articles
-
Nonspecific enhancement of resistance to local bacterial infection in starved mice.Arch Surg. 1982 Feb;117(2):161-4. doi: 10.1001/archsurg.1982.01380260041007. Arch Surg. 1982. PMID: 7034676
-
Amelioration by muramyl dipeptide of the effect of induced hyperferremia upon Klebsiella infection in mice.Infect Immun. 1982 Oct;38(1):175-8. doi: 10.1128/iai.38.1.175-178.1982. Infect Immun. 1982. PMID: 6754611 Free PMC article.
-
The enhancement of host defenses against infection--search for the Holy Grail?Surgery. 1986 Jan;99(1):1-6. Surgery. 1986. PMID: 3941994
-
Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators.Clin Infect Dis. 1992 May;14(5):1100-9. doi: 10.1093/clinids/14.5.1100. Clin Infect Dis. 1992. PMID: 1600012 Review.
-
[Muramyl dipeptide derivatives in experimental and clinical use].Zh Mikrobiol Epidemiol Immunobiol. 1998 Jan-Feb;(1):104-8. Zh Mikrobiol Epidemiol Immunobiol. 1998. PMID: 9532704 Review. Russian. No abstract available.
Cited by
-
Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.Infect Immun. 1992 Jan;60(1):95-101. doi: 10.1128/iai.60.1.95-101.1992. Infect Immun. 1992. PMID: 1729201 Free PMC article.
-
Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.Infect Immun. 1992 Nov;60(11):4891-7. doi: 10.1128/iai.60.11.4891-4897.1992. Infect Immun. 1992. PMID: 1399000 Free PMC article.
-
Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.Folia Microbiol (Praha). 1992;37(2):146-52. doi: 10.1007/BF02836620. Folia Microbiol (Praha). 1992. PMID: 1505872
-
Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.Antimicrob Agents Chemother. 1994 Jan;38(1):147-50. doi: 10.1128/AAC.38.1.147. Antimicrob Agents Chemother. 1994. PMID: 8141571 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources